StockWatch
·
Pharmaceuticals
Board Meeting10 Nov 2026, 04:50 pm

Decipher Labs Board Meeting on Nov 14 to Approve Q2 Results

AI Summary

Decipher Labs Ltd has announced that its Board of Directors will convene on November 14, 2026. The primary agenda item is the consideration and approval of the un-audited standalone and consolidated financial results for the Quarter and Half Year ended September 30, 2026. Additionally, the board will review the Limited Review Report for the same period. The meeting will be held at the company's registered office.

Key Highlights

  • Board meeting scheduled for November 14, 2026.
  • Approval of un-audited standalone and consolidated results.
  • Review of Limited Review Report for Q2 FY27.
  • Meeting to consider financial performance for the quarter and half-year ended September 30, 2026.